ArticleOpen veterinary journal2026
Cholesterol and testosterone dynamics in a polycystic ovary syndrome animal model.
Article in Open veterinary journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Polycystic ovary syndrome (PCOS) is a complex endocrine disorder characterized by hyperandrogenism, elevated luteinizing hormone, reduced follicle-stimulating hormone, increased estrogen/estradiol levels, anovulation/oligoovulation, and dyslipidemia, including elevated blood cholesterol levels. Understanding the interplay between hormonal imbalances and metabolic dysregulation in patients with PCOS remains a critical area of research. Aim: This study aimed to identify the impact of testosterone propionate and estradiol benzoate on cholesterol and testosterone levels in a rat model of PCOS. Methods: This study employed a testosterone propionate (TP) and estradiol benzoate (EB) induced female Wistar rat model of PCOS to explore a possible link between cholesterol and testosterone levels in the context of hormonal and metabolic interactions inherent to the syndrome. Six-month-old female Wistar rats (130-150 g) were randomly allocated into three experimental groups: Animals were divided into three groups: NC (corn oil, 100 µl, i.p.), TP (testosterone propionate 100 mg/kg BW, i.p., 12 days), and EB (estradiol benzoate 2 mg/kg BW, i.p., 2 days). Results: Serum cholesterol and testosterone levels were measured and compared across the groups. Induction with TP and EB did not significantly alter cholesterol levels in the PCOS model compared with the negative control group ( Conclusion: The findings indicate that estradiol benzoate, but not testosterone propionate, significantly elevates testosterone levels in this PCOS model, without a corresponding impact on cholesterol levels. These results underscore the differential effects of hormonal induction on androgen production and lipid metabolism, providing insights into PCOS's complex pathophysiology. Further research is required to explore the mechanisms underlying these hormonal and metabolic interactions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.